Medicare Enrolled

Dr. Galina Vugman, MD

Hematology & Oncology · Sarasota, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
5951 CATTLERIDGE AVE, Sarasota, FL 34232
9412001125
In practice since 2006 (19 years)
NPI: 1093891673 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vugman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vugman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vugman

Dr. Galina Vugman is a hematology & oncology in Sarasota, FL, with 19 years in practice. Based on federal Medicare data, Dr. Vugman performed 85,852 Medicare services across 3,108 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vugman received a total of $2,521 from 29 pharmaceutical and/or device companies across 74 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vugman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 9% volume in FL$ $2,521 industry payments

Medicare Practice Summary

Medicare Utilization ↗
85,852
Medicare services
Top 9% in FL for hematology & oncology
3,108
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,519 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Feraheme)52,530$0$2
Pembrolizumab injection (Keytruda)11,800$42$123
Denosumab injection (Prolia/Xgeva)5,100$18$48
Paclitaxel chemotherapy injection4,809$0$1
Dexamethasone injection (steroid)2,140$0$1
Epoetin alfa injection (Retacrit) for anemia1,520$6$21
Anti-nausea injection (Aloxi/palonosetron)1,451$1$31
Office visit, established patient (30-39 min)853$92$202
Office visit, established patient (20-29 min)606$61$135
Anti-nausea injection (ondansetron/Zofran)488$0$1
Injection, carboplatin, 50 mg393$2$8
Administration of chemotherapy into vein, 1 hour or less369$98$327
Complete blood count (CBC) with differential294$8$22
Blood draw (venipuncture)287$8$14
Comprehensive metabolic blood panel281$10$30
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less266$22$74
Drug injection, under skin or into muscle224$10$50
Office visit, established patient, complex (40-54 min)216$133$279
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less169$48$154
Hospital follow-up visit, moderate complexity155$64$138
Administration of additional new drug or substance into vein, 1 hour or less137$50$152
New patient office visit, complex (60-74 min)118$165$412
Injection, zoledronic acid, 1 mg114$7$59
New patient office visit (45-59 min)106$124$328
Irrigation of implanted venous access drug delivery device101$14$60
Collection of blood sample from implanted device87$15$50
Administration of chemotherapy into vein, each additional hour87$22$69
Ferritin level test (iron stores)83$13$39
Iron level test83$6$18
Iron binding capacity test79$9$24
Initial hospital admission, high complexity75$137$386
Injection, diphenhydramine hcl, up to 50 mg70$1$3
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle69$49$172
Leuprolide acetate (for depot suspension), 7.5 mg57$138$545
Infusion, normal saline solution , 1000 cc56$2$6
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle55$23$80
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg54$1$6
Injection of additional new drug or substance into vein48$12$49
Administration of additional new drug or substance into vein using push technique44$43$147
Hospital follow-up visit, high complexity42$93$198
Infusion into a vein for hydration, 31-60 minutes39$24$125
Infusion into a vein for hydration, each additional hour37$10$33
Vitamin B-12 level test32$15$43
Red blood count automated, with additional calculations32$5$11
Hospital follow-up visit, low complexity30$40$76
Thyroid stimulating hormone (TSH) test29$16$48
Folic acid level test25$14$42
Free thyroxine (T4) test21$9$25
Complete blood count (CBC), automated19$6$18
Microscopic examination for white blood cells with manual cell count18$4$10
Sed rate test (inflammation marker)16$3$8
Testosterone (hormone) level, total14$25$71
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional12$15$40
Office visit, established patient (10-19 min)12$34$81
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
61.8% high complexity
33.5% medium
4.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,521
Total received (2018-2024)
Avg $420/year across 6 years
Bottom 41% in FL for hematology & oncology
29
Companies
74
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,318 (91.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$203 (8.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,072
2023
$900
2022
$110
2021
$12
2019
$289
2018
$137

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$337
Novartis Pharmaceuticals Corporation
$293
PFIZER INC.
$226
GENZYME CORPORATION
$219
Celgene Corporation
$177
Gilead Sciences, Inc.
$169
AstraZeneca Pharmaceuticals LP
$165
E.R. Squibb & Sons, L.L.C.
$137
Genentech USA, Inc.
$121
PharmaEssentia USA Corporation
$84
Merck Sharp & Dohme LLC
$78
Myriad Genetic Laboratories, Inc.
$69
Incyte Corporation
$52
Alnylam Pharmaceuticals Inc.
$48
Astellas Pharma US Inc
$40
Janssen Biotech, Inc.
$35
Amneal Pharmaceuticals LLC
$27
Pharmacosmos Therapeutics Inc.
$26
ACCORD HEALTHCARE, INC.
$23
ARRAY BIOPHARMA INC
$22
Daiichi Sankyo Inc.
$22
Tempus AI, Inc
$22
Ipsen Biopharmaceuticals, Inc
$20
EMD Serono, Inc.
$20
Exelixis Inc.
$19
MorphoSys, US Inc.
$18
TAIHO ONCOLOGY, INC.
$18
Stemline Therapeutics Inc.
$17
NESTLE HEALTHCARE NUTRITION INC.
$16
Top 3 companies account for 34.0% of total payments
Associated products mentioned in payments ›
AVASTIN · BESREMI · BRAFTOVI · CABOMETYX · CALQUENCE · CAMCEVI · DARZALEX · ENHERTU · GAZYVA · IBRANCE · INJECTAFER · INLYTA · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · LONSURF · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · ONPATTRO · OPDIVO · Orserdu · PIQRAY · PLUVICTO · Perjeta · Pomalyst · REBLOZYL · SARCLISA · TAGRISSO · TECVAYLI · VERQUVO · VERZENIO · VOWST · VYNDAQEL · XTANDI · Xospata · Xtandi · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3 per 100 Medicare services performed
Looking for a hematology & oncology in Sarasota?
Compare hematology & oncologys in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
17
Per 100K population
3.8
County median income
$80,633
Nearest hospital
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
3.1 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Vugman is a mixed practice specialist, with above-average Medicare volume (top 9% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Vugman experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Vugman performed 52,530 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vugman receive payments from pharmaceutical companies?
Yes. Dr. Vugman received a total of $2,521 from 29 companies across 74 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vugman's costs compare to other hematology & oncologys in Sarasota?
Dr. Vugman's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vugman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →